Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Vascular endothelial growth factor inhibition and proliferative diabetic retinopathy, a changing treatment paradigm?

Authors:
Lihteh Wu Dhariana Acón Andrés Wu Max Wu

Taiwan J Ophthalmol 2019 Oct-Dec;9(4):216-223. Epub 2019 Dec 13.

Macula, Vitreous and Retina Associates of Costa Rica, San José, Costa Rica, USA.

Prior to the development of panretinal photocoagulation (PRP) in the 1970s, proliferative diabetic retinopathy (PDR) was the most common cause of blindness in diabetic patients. The diabetic retinopathy study demonstrated that PRP could decrease severe visual loss from PDR by 50%. Since then and for the past four decades, PRP has been the treatment of choice for eyes with PDR. In the past decade, vascular endothelial growth factor (VEGF) inhibition has become the treatment of choice for diabetic macular edema (DME). When treated intensively with anti-VEGF drugs, about one-third of eyes with DME experience an improvement in their diabetic retinopathy severity scale. Randomized clinical trials comparing ranibizumab to PRP and aflibercept to PRP have shown that VEGF inhibitors cause regression of intraocular neovascularization but need to be given on a fairly regular basis. Despite these promising results, concerns about treatment adherence have surfaced. Patients with PDR that are treated solely with anti-VEGF drugs and somehow interrupt their treatment are at a high risk of developing irreversible blindness. Combination treatment of PRP plus an anti-VEGF drug may be the treatment of choice for PDR.

Download full-text PDF

Source
http://dx.doi.org/10.4103/tjo.tjo_67_19DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6947741PMC
December 2019

Publication Analysis

Top Keywords

diabetic retinopathy
16
treatment choice
12
proliferative diabetic
8
growth factor
8
anti-vegf drugs
8
vascular endothelial
8
endothelial growth
8
treatment
7
diabetic
6
prp
6
pdr
5
vegf inhibition
4
factor vegf
4
prp aflibercept
4
aflibercept prp
4
inhibition treatment
4
choice diabetic
4
macular edema
4
drugs interrupt
4
diabetic macular
4

Altmetric Statistics


Show full details
1 Total Shares
1 Tweets
1 Citations

Similar Publications

Retinal Nrf2 expression in normal and early streptozotocin-diabetic rats.

Authors:
Jesús Silvestre Albert-Garay Juan Rafael Riesgo-Escovar Gustavo Sánchez-Chávez Rocío Salceda

Neurochem Int 2021 Mar 3:105007. Epub 2021 Mar 3.

Instituto de Fisiología Celular, Departamento de Neurodesarrollo y Fisiología, Universidad Autónoma de México, CDMX, México.

Diabetic retinopathy is the most common cause of vision loss among diabetic patients. Although hyperglycemia produces retinal oxidative stress in long-standing diabetes, the pathogenesis mechanism is unknown. The Nuclear factor erythroid 2-related factor 2 (Nrf2) plays a central role in cell responses against oxidative damage. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Alleviating an Increasingly Burdened Healthcare System with Telemedicine: Anterior Segment.

Authors:
Karam A Alawa Christopher S Sales

Ophthalmol Ther 2021 Mar 6. Epub 2021 Mar 6.

Department of Ophthalmology, University of Iowa Hospital and Clinics, Iowa City, IA, USA.

Tele-ophthalmology is a rapidly evolving and exciting field that has become increasingly relevant amidst the current global pandemic. With advancements in technology, many components of an evaluation previously possible only in an office setting are becoming possible remotely, paving the way for at-home visits. Examples of these technologies include measurement of visual acuity using smartphones, remote monitoring of intraocular pressure using self-administered tonometers or implantable sensors, and use of digitally acquired slit-lamp or smartphone images for diagnosis of anterior segment pathology. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Outcomes of macular buckling surgery in myopic foveal detachment eyes with and without disrupted ellipsoid zone band: a case-control study.

Authors:
Jun Li Yonghao Li Shida Chen Wei Ma Xiujuan Zhao Xia Huang Ping Lian Bingqian Liu Lin Lu

Graefes Arch Clin Exp Ophthalmol 2021 Mar 6. Epub 2021 Mar 6.

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, 510060, China.

Purpose: To compare the outcomes of macular buckling (MB) surgery between myopic foveal detachment (FD) eyes with and without ellipsoid zone (EZ) disruption.

Methods: A retrospective, case-control study. Forty-four consecutive eyes from 44 patients received MB surgery for myopic FD between November 2017 and January 2019 were included. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Pathogenesis study based on high throughput single-cell sequencing analysis reveals novel transcriptional landscape and heterogeneity of retinal cells in type 2 diabetic mice.

Authors:
Tian Niu Junwei Fang Xin Shi Mengya Zhao Xindan Xing Yihan Wang Shaopin Zhu Kun Liu

Diabetes 2021 Mar 5. Epub 2021 Mar 5.

Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, 20080, China

Diabetic retinopathy (DR) is the leading cause of acquired blindness in middle-aged people. The complex pathology of DR is difficult to dissect, given the convoluted cytoarchitecture of the retina. Here, we performed single-cell RNA sequencing (scRNA-seq) of retina from type 2 diabetic model induced in leptin receptor-deficient (db/db) and control db/m mice with the aim of elucidating the factors mediating the pathogenesis of DR. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

The Role of Autophagy in Eye Diseases.

Authors:
José A Fernández-Albarral Esther de Julián-López Carmen Soler-Domínguez Rosa de Hoz Inés López-Cuenca Elena Salobrar-García José M Ramírez María D Pinazo-Durán Juan J Salazar Ana I Ramírez

Life (Basel) 2021 Feb 27;11(3). Epub 2021 Feb 27.

Instituto de Investigaciones Oftalmológicas Ramón Castroviejo, Universidad Complutense de Madrid (UCM), 28040 Madrid, Spain.

Autophagy is a catabolic process that ensures homeostasis in the cells of our organism. It plays a crucial role in protecting eye cells against oxidative damage and external stress factors. Ocular pathologies of high incidence, such as age-related macular degeneration, cataracts, glaucoma, and diabetic retinopathy are of multifactorial origin and are associated with genetic, environmental factors, age, and oxidative stress, among others; the latter factor is one of the most influential in ocular diseases, directly affecting the processes of autophagy activity. Read More

View Article and Full-Text PDF
February 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap